Dabigatran Etexilate (Pradaxa) And Intracranial Hemorrhage
5/03/2013
The Journal of Neurosurgery Publishing Group is pleased to announce publication of two new studies on dabigatran etexilate (Pradaxa®) and intracranial hemorrhage: one in the Journal of Neurosurgery and the other in Neurosurgical Focus...
Discovery Of Mutation Driving Pediatric Brain Tumors
5/03/2013
A type of low-grade but sometimes lethal brain tumor in children has been found in many cases to contain an unusual mutation that may help to classify, diagnose and guide the treatment of the tumors, report scientists at Dana-Farber Cancer Institute...
The OGX-427 ORCA™ Program Continues to Expand with Patient Enrollment Now Open for Second Phase 2 Trial of OGX-427 in Advanced Bladder Cancer OncoGenex Pharmaceuticals, Inc...
UF Researchers Develop 'Nanotrain' For Targeted Cancer Drug Transport
5/02/2013
University of Florida researchers have developed a "DNA nanotrain" that fast-tracks its payload of cancer-fighting drugs and bioimaging agents to tumor cells deep within the body...
New DNA Blood Test Could Increase Access To Herceptin
5/02/2013
A new blood test for women with breast cancer could identify more women who will benefit from the targeted treatment Herceptin without the need for uncomfortable biopsies. The new 'liquid biopsy' uses cutting-edge genetic techniques to detect breast cancer DNA in the bloodstream, and was developed by a team at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust...
Dogs Can Detect Breast And Lung Cancer Cells In Vitro
5/02/2013
Researcher Hopes to Screen Smokers with Early Stage Lung Disease in Next Research Phase An internist and instructor at Ben-Gurion University of the Negev has conducted research proving that specially trained dogs can differentiate the smell of breast cancer cells from non-cancerous cells in cell cultures...
First Comprehensive Analysis Reveals Long-term Effectiveness Of SERMs For Preventing Breast Cancer
5/02/2013
Selective oestrogen receptor modulators (SERMs: tamoxifen, raloxifene, arzoxifene, and lasofoxifene) significantly reduce the risk of developing the most common type of breast cancer among women at both high and average risk of the disease* both during treatment, and for at least 5 years after stopping, according to the first comprehensive analysis of all SERM prevention trials...
Lung Cancer Survival Improved By Chemo, Radiation, Then Surgery
5/02/2013
In one of the largest observational studies of its kind, researchers report that a combination of chemotherapy and radiation followed by surgery in patients with stage 3 non-small cell lung cancer improves survival. Patients who had chemoradiation therapy followed by surgery had twice the five-year survival rate of those who had only chemoradiation, says Dr...
Longer Sleep Duration Associated With Increased Risk Of Developing Colorectal Cancer
5/02/2013
A new study is the first to report a significant positive association between long sleep duration and the development of colorectal cancer, especially among individuals who are overweight or snore regularly. The results raise the possibility that obstructive sleep apnea may contribute to cancer risk...
Therapeutic Proteins Could Offer Much Needed Treatment Strategy For Metastatic Cancer
5/02/2013
Cancer spread or metastasis can strike unprecedented fear in the minds of cancer patients. The "seed and the soil" hypothesis proposed by Stephen Paget in 1889 is now widely accepted to explain how cancer cells (seeds) are able to generate fertile soil (the microenvironment) in distant organs that promotes cancer's spread...